Page last updated: 2024-08-26

artenimol and Acute Lung Injury

artenimol has been researched along with Acute Lung Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hao, CX; Huang, XT; Liu, W; Luo, ZQ; Sun, CC; Tang, SY; Zhang, CY; Zhou, Y	1

Other Studies

1 other study(ies) available for artenimol and Acute Lung Injury

Article	Year
Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner. International journal of molecular medicine, 2019, Volume: 44, Issue:6 Topics: Acute Lung Injury; Animals; Artemisinins; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Lung; Macrophages; Mice; NF-E2-Related Factor 2; NF-kappa B; Signal Transduction; Tumor Necrosis Factor-alpha	2019

Article

Year

Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner.

International journal of molecular medicine, 2019, Volume: 44, Issue:6

Topics: Acute Lung Injury; Animals; Artemisinins; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Lung; Macrophages; Mice; NF-E2-Related Factor 2; NF-kappa B; Signal Transduction; Tumor Necrosis Factor-alpha

2019